These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
393 related articles for article (PubMed ID: 25778766)
1. Synthesis and biological evaluation of benzimidazole acridine derivatives as potential DNA-binding and apoptosis-inducing agents. Gao C; Li B; Zhang B; Sun Q; Li L; Li X; Chen C; Tan C; Liu H; Jiang Y Bioorg Med Chem; 2015 Apr; 23(8):1800-7. PubMed ID: 25778766 [TBL] [Abstract][Full Text] [Related]
2. Novel synthetic acridine derivatives as potent DNA-binding and apoptosis-inducing antitumor agents. Lang X; Li L; Chen Y; Sun Q; Wu Q; Liu F; Tan C; Liu H; Gao C; Jiang Y Bioorg Med Chem; 2013 Jul; 21(14):4170-7. PubMed ID: 23735826 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiproliferative activity of 9-benzylamino-6-chloro-2-methoxy-acridine derivatives as potent DNA-binding ligands and topoisomerase II inhibitors. Zhang W; Zhang B; Zhang W; Yang T; Wang N; Gao C; Tan C; Liu H; Jiang Y Eur J Med Chem; 2016 Jun; 116():59-70. PubMed ID: 27060757 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents. Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S J Med Chem; 2003 Jul; 46(14):3109-15. PubMed ID: 12825949 [TBL] [Abstract][Full Text] [Related]
5. Isoquino[4,5-bc]acridines: design, synthesis and evaluation of DNA binding, anti-tumor and DNA photo-damaging ability. Yang P; Yang Q; Qian X; Tong L; Li X J Photochem Photobiol B; 2006 Sep; 84(3):221-6. PubMed ID: 16714120 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of new asymmetrical bisintercalators as potential antitumor drugs. Antonini I; Santoni G; Lucciarini R; Amantini C; Sparapani S; Magnano A J Med Chem; 2006 Nov; 49(24):7198-207. PubMed ID: 17125272 [TBL] [Abstract][Full Text] [Related]
7. 4-Hydroxymethyl-3-aminoacridine derivatives as a new family of anticancer agents. Charmantray F; Demeunynck M; Carrez D; Croisy A; Lansiaux A; Bailly C; Colson P J Med Chem; 2003 Mar; 46(6):967-77. PubMed ID: 12620073 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, cytotoxic activities and proposed mode of binding of a series of bis([(9-oxo-9,10-dihydroacridine-4-carbonyl)amino]alkyl) alkylamines. Braña MF; Casarrubios L; Domínguez G; Fernández C; Pérez JM; Quiroga AG; Navarro-Ranninger C; de Pascual-Teresa B Eur J Med Chem; 2002 Apr; 37(4):301-13. PubMed ID: 11960665 [TBL] [Abstract][Full Text] [Related]
9. Acridine derivatives as chemotherapeutic agents. Denny WA Curr Med Chem; 2002 Sep; 9(18):1655-65. PubMed ID: 12171548 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, interaction with DNA and antiproliferative activities of two novel Cu(II) complexes with norcantharidin and benzimidazole derivatives. Song WJ; Lin QY; Jiang WJ; Du FY; Qi QY; Wei Q Spectrochim Acta A Mol Biomol Spectrosc; 2015 Feb; 137():122-8. PubMed ID: 25218220 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, antiproliferative activity and DNA binding properties of novel 5-aminobenzimidazo[1,2-a]quinoline-6-carbonitriles. Perin N; Nhili R; Ester K; Laine W; Karminski-Zamola G; Kralj M; David-Cordonnier MH; Hranjec M Eur J Med Chem; 2014 Jun; 80():218-27. PubMed ID: 24780599 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and preliminary evaluation of selected 2-aryl-5(6)-nitro- 1H-benzimidazole derivatives as potential anticancer agents. Romero-Castro A; León-Rivera I; Avila-Rojas LC; Navarrete-Vázquez G; Nieto-Rodríguez A Arch Pharm Res; 2011 Feb; 34(2):181-9. PubMed ID: 21380799 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and evaluation of acridine derivatives as multi-target Src and MEK kinase inhibitors for anti-tumor treatment. Cui Z; Li X; Li L; Zhang B; Gao C; Chen Y; Tan C; Liu H; Xie W; Yang T; Jiang Y Bioorg Med Chem; 2016 Jan; 24(2):261-9. PubMed ID: 26707846 [TBL] [Abstract][Full Text] [Related]
14. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents. Antonini I; Polucci P; Magnano A; Sparapani S; Martelli S J Med Chem; 2004 Oct; 47(21):5244-50. PubMed ID: 15456268 [TBL] [Abstract][Full Text] [Related]
16. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome. Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647 [TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of threading intercalators to target DNA. Howell LA; Gulam R; Mueller A; O'Connell MA; Searcey M Bioorg Med Chem Lett; 2010 Dec; 20(23):6956-9. PubMed ID: 20980148 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological research of novel azaacridine derivatives as potent DNA-binding ligands and topoisomerase II inhibitors. Li D; Yuan Z; Chen S; Zhang C; Song L; Gao C; Chen Y; Tan C; Jiang Y Bioorg Med Chem; 2017 Jul; 25(13):3437-3446. PubMed ID: 28511910 [TBL] [Abstract][Full Text] [Related]
19. Triazine-benzimidazole hybrids: anticancer activity, DNA interaction and dihydrofolate reductase inhibitors. Singla P; Luxami V; Paul K Bioorg Med Chem; 2015 Apr; 23(8):1691-700. PubMed ID: 25792141 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro cytotoxic evaluation of some thiazolylbenzimidazole derivatives. Luo Y; Xiao F; Qian S; Lu W; Yang B Eur J Med Chem; 2011 Jan; 46(1):417-22. PubMed ID: 21115212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]